News for:

 

Click the Chemical Profile link above for detailed information. Visit Betterchem's Drug Index for… Exclusivity Patents and market exclusivity Drug Information Prescribing and other information DMFs Type 2 drug master files Databases Free access to database search 21 CFR FDA regulations for this drug Federal Register FR search results for this drug Drug Recalls For Rx's using this API

FDA Approval Activities for this Drug… Cozaar (losartan potassium) Tablets, Merck & Co., NDA 20-386/S032 3/25/03 4/1/03 4/1/03 7/8/03 Cozaar (losartan potassium) Tablets, 25, 50, & 100 mg, Merck & Co., NDA 20-386/S028 9/17/02 9/20/02 9/17/02 2/4/03 Cozaar (losartan potassium) Tablets, 25, 50, & 100 mg; Hyzaar (losartan potassium / hydrochlorothiazide) Tablets, 50-12.5 & 100-25 Merck & Co., NDA 20-386/S020 & 20-387/S017 1/19/00 6/6/01 Cozaar (losartan potassium) Tablets, 25, 50, & 100 mg; Hyzaar (losartan potassium / hydrochlorothiazide) Tablets, 50-12.5 & 100-25 Merck & Co., NDA 20-386/S018 & 20-387/S014 1/28/00 6/6/01 Cozaar (losartan potassium) Tablets, 25 & 50 mg Merck Research NDA 20-386/S-015 11/24/98 3/13/00 Cozaar (losartan potassium) Tablets, 25 & 50 mg Merck Research NDA 20-386/S-008 10/13/98 9/14/01 Cozaar (losartan potassium) Tablets, 25 & 50 mg Merck & Co. NDA 20-386/S-017 Hyzaar (losartan potassium/hydrochlorothiazide), Merck & Co., NDA 20-387/S-013 & S-015 & S-027 9/30/03 10/10/03 10/10/03 Hyzaar (losartan potassium/hydrochlorothiazide) Tablets, 50/12.5 and 100/25 mg. Merck & Co., NDA 20-387/S-024 11/7/02 11/18/02 Hyzaar (losartan potassium/hydrochlorothiazide) Tablets, 50-12.5 mg Merck Research NDA 20-387/S6 8/24/98 12/3/01 Hyzaar (losartan potassium/hydrochlorothiazide) Tablets, 50-12.5 mg Merck Research NDA 20-387/S8 11/10/98 12/3/01 Hyzaar 50-12.5 (losartan potassium/hydrochlorothiazide) Tablets, 50-12.5 mg Merck Research NDA 20-387/S10 8/25/98 12/3/01 Hyzaar 50 (losartan potassium/hydrochlorothiazide) Tablets, 50-12.5 mg Merck Research NDA 20-387/S-011 11/24/98 3/13/00 Hyzaar 50 (losartan potassium/hydrochlorothiazide) Tablets, 50-12.5 mg & 100-25 mg Merck Research NDA 20-387/S-012 Cozaar (losartan potassium) Tablets, Merck and Co., Inc. | Hyzaar (losartan potassium-hydrochlorothiazide) Tablets, Merck & Co., Efficacy Supplement w/Clinical Data Support | Cozaar (losartan potassium) Tablets, Merck & Co., Labeling Revision | Hyzaar (losartan potassium-hydrochlorothiazide) Tablets, Merck & Co., Labeling Revision | HYZAAR (losartan/potassium hydrochlorothiazide) Tablets, Merck Research, New Dosage Regimen | COZAAR (losartan potassium) Tablets, Merck Research, Labeling Revision | HYZAAR (losartan potassium hydrochlorothiazide) Tablets, Merck Research, Labeling Revision | Losartan Potassium Tablets, Roxane Labs, Tentative Approval | Losartan Potassium Tablets, Teva Pharma, Tentative Approval | Losartan Potassium and Hydrochlorothiazide Tablets, Teva Pharma, Tentative Approval | Losartan Potassium & Hydrochlorothiazide Tablets, Roxane Labs, Tentative Approval | Losartan Potassium & Hydrochlorothiazide Tablets, Roxane Labs, Tentative Approval | Cozaar Tablet, Merck, Labeling Revision | Hyzaar Tablet, Merck, Labeling Revision | Cozaar (losartan potassium) Tablets, Merck & Co., Labeling Revision | Hyzaar (losartan potassium/hydrochlorothiazide) Tablets, Merck Research Labs, Labeling Revision Visit Betterchem's Drug Index for FDA's latest approval information.   Find other drugs… A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | USActives.com | Pharma Job Search | Pharma Company News © 2011 FindingHealthOnline™